SCHEMBL15024697

SCHEMBL15024697

CC(=O)c1cc(C)nc2c1cnn2C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 4/20 0.38
UTS2R Q9UKP6 1/20 0.36
PDE2A O00408 1/20 0.36
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
MAPT P10636 2/20 0.36
CYP3A4 P08684 1/20 0.36
TLR9 Q9NR96 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
CYP1A2 P05177 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TP53 P04637 1/20 0.35
ATAD2 Q6PL18 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15024702 0.87 KDM4E (0.54) KDM4ESMN1; SMN2ALDH1A1UTS2RF7
SCHEMBL15024648 0.84 PDE2A (0.36) KDM4ESMN1; SMN2ALDH1A1PDE2AF7
SCHEMBL30935932 0.76 PDE2A (0.40) KDM4EALDH1A1UTS2RPDE2AF7
SCHEMBL20674220 0.76 PDE2A (0.40) KDM4EALDH1A1UTS2RPDE2AF7
SCHEMBL23872469 0.75 PDE2A (0.42) KDM4EALDH1A1PDE2AF7F3
SCHEMBL19953294 0.73 KMT2A (0.40) KDM4EALDH1A1PDE2AF7F3
SCHEMBL29133371 0.73 PDE2A (0.47) KDM4EALDH1A1PDE2AMAPTCYP3A4
SCHEMBL24654997 0.73 KMT2A (0.41) KDM4EALDH1A1PDE2AF7F3
SCHEMBL30899643 0.73 PDE2A (0.40) ALDH1A1PDE2AF7F3TP53
SCHEMBL29786789 0.73 KMT2A (0.40) KDM4EALDH1A1PDE2AF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130150340-A1 6-(4-Hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors SANOFI (FR) 2013-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150340-A1 6-(4-Hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors MAP3K1, MAP4K2, MAP3K19 KDM4E 748/4885SMN1; SMN2 2861/4885ALDH1A1 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.